ISTA Pharmaceuticals, Inc. (NASDAQ:ISTA)

CAPS Rating: 2 out of 5

An ophthalmic pharmaceutical company, focused on the development and commercialization of products for serious diseases and conditions of the eye.

Featured Broker Partners


Advertisement